FDA Device Recall Z-2384-2023

Covidien LP · Mansfield, MA

Class I — life-threatening Ongoing

Highest impact — Class I device recall — FDA determination that use of, or exposure to, the device will cause serious adverse health consequences or death. Distribution is nationwide and the recall remains in progress.

Device

MAHURKAR 12 Fr Triple Lumen Acute Dialysis Catheter, 13 cm, Curved Extensions, Kit" REF: 8888345603

Lot / serial / GTIN: GTIN: 10884521006768/ 20884521006765 LOT Numbers: 1907700093 1908400296 1914400157 1914400158 1914800241 1914800242 1914800243 1915800144 1915800145 1916500157 1920700126 1921100198 1921100199 1921100201 1921300056 1921300057 1928700083 1932300211 2000700063 2000700064 2001400084 2002100115 2002900099 2002900103 2002900104 2005700211 2005700212 2007800069 2007800070 2007800088 2009000047 2009400127 2010800201 2010800203 2010800204 2010800206 2010800207 2015100040 2015100043 2017400082 2019500192 2131200161 2131200162 2131200163 2227800106 2227800111 2227800112 2227800114 2227800115 2230400303 2230400304 2232700203

Quantity: 45880 units

Reason for recall

Catheter center lumen was found to have an occlusion in the tip of the catheter; the source of the occlusion an excessive MDX, a silicone-based lubricant which coats the catheter tip. An occluded, partially or fully, and/or uncured or excessive MDX may dislodge from the catheter lead to full catheter obstruction resulting in delay to treatment and partial obstruction resulting in reduced flow, or particulate dislodgement that may result in delay to treatment, hemolysis, embolism/embolus or thrombosis/thrombus

Recall record

Recall number: Z-2384-2023
Classification: Class I
Status: Ongoing
Voluntary or mandated: Voluntary: Firm initiated
Firm notification: Letter
Distribution: US Nationwide - Worldwide Distribution Foreign: Argentina Austria Bahrain Bangladesh Belgium Brazil Brunei Darussalam Canada Cayman Islands China Costa Rica Czech Republic Denmark Dominican Republic Finland France French Polynesia Germany Greece Hungary India Iran, Islamic Republic Of Ireland Italy Kuwait Malaysia Maldives Mauritius Mexico Nepal Netherlands New Caledonia Nicaragua Norway Philippines Poland Portugal Puerto Rico Saudi Arabia Singapore Slovakia South Africa Spain Sri Lanka Sweden Switzerland Thailand Turkey United Arab Emirates United Kingdom
Recall initiated: 2023-06-28
Classified by FDA Center: 2023-08-11
FDA published: 2023-08-23
Recalling firm: Covidien LP
Firm location: Mansfield, MA

Operational response

A Class I device recall indicates a strong likelihood of serious adverse health consequence or death from continued use. Identify affected units by serial number, lot, or GTIN against your inventory and against implanted-device patient registry. Pull affected inventory from active use immediately. For implanted devices, follow the recalling firm’s patient-notification protocol; in most cases this requires informing affected patients and their treating physicians directly.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All device recalls